News Clip0:29
Curated Video

Pfizer Agrees To Let Other Companies Manufacture Its COVID-19 Pill

Higher Ed
The drugmaker won't receive royalties on sales in low-income countries and will waive royalties where the virus is still a public health emergency.
News Clip7:30
Bloomberg

Ex-FDA Commissioner McClellan on Pfizer Vaccine, Delta Spread

Higher Ed
Aug.23 -- Former FDA Commissioner Dr. Mark McClellan, founding director of the Margolis Center for Health Policy at Duke University, reacts to U.S. regulators granting full approval to the Covid-19 vaccine made by Pfizer and BioNTech. He...
News Clip3:05
The Recount

America Is Diversifying Faster Than Ever

Higher Ed
The FDA will allow COVID booster shots for immunocompromised people. The Census Bureau data reveals America is diversifying faster than ever. And it turns out, if you build it, they really will come. Just look at the MLB Field of Dreams...
News Clip1:52
Curated Video

FDA May Authorize Second COVID Booster For People Over 50

Higher Ed
The Biden administration is expected to give older adults the option of getting a second COVID-19 vaccine booster as early as Tuesday.
News Clip2:47
Bloomberg

Trump Seeks Quick FDA Approvals of Covid-19 Treatments

Higher Ed
Apr.29 -- President Trump says he wants to see quick Food and Drug Administration approvals on drugs that work and that recent Gilead Sciences Inc. coronavirus-drug trial results are a “building block.” The Trump administration is...
News Clip1:11
Curated Video

Trump Administration Moves To Expand Coronavirus Testing

Higher Ed
Both the Department of Health and Human Services and FDA announced new efforts to boost coronavirus test availability.
News Clip2:50
Curated Video

2 More Possible Vaccines Get A Fast Track, Raising Wall Street Hopes

Higher Ed
Two more coronavirus vaccine candidates are in a fast lane for FDA approval. But experts say the road to an effective vaccine still has speed bumps.
News Clip0:29
News Clip1:35
Bloomberg

Trump Says Politics Could Be Holding Back Covid Plasma Treatment

Higher Ed
Aug.19 -- President Donald Trump alleged that U.S. health regulators may be delaying the emergency authorization of blood plasma to treat coronavirus patients until after the election to hurt him politically, offering no substantiation...
News Clip1:32
Curated Video

Health Experts Optimistic On Vaccine Approval By End of 2020

Higher Ed
Dr. Anthony Fauci told senators he is "cautiously optimistic" on vaccine approval by year's end.
News Clip3:08
Curated Video

What's Next For A COVID-19 Vaccine?

Higher Ed
If a vaccine is approved soon, vaccinations could start in December, but supply will be limited at first.
News Clip4:45
Bloomberg

FDA Vaccine Approval to Help Public Acceptance: Johns Hopkins

Higher Ed
Dec.07 -- Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses the start of vaccinations in the U.K., distribution complications for the U.S., and continuing tracking, tracing, and social distancing along...
News Clip0:31
Curated Video

Teens Could Get Pfizer Shot This Week

Higher Ed
The C.D.C. Is also expected to agree with the recommendation meaning shots could start in a matter of days.
News Clip0:28
Curated Video

BioNTech, Pfizer Say Their Coronavirus Vaccine Is Close To Approval

Higher Ed
Their vaccine is currently in Phase 3 trials. The FDA and Europe's EMA will take it up for approval either next month or in November.
News Clip1:00
Curated Video

FDA To Authorize Pfizer COVID Shot For Kids Ages 12-15

Higher Ed
Right now, the shot is only available for those over 16.
News Clip0:28
Curated Video

CDC Panel Recommends Third Dose For Immunocompromised People

Higher Ed
The FDA already changed its emergency use authorization for the shots.
News Clip0:29
Curated Video

Johnson & Johnson Vaccine Becomes Third Approved In U.S.

Higher Ed
The FDA granted emergency approval for Johnson & Johnson's single-dose vaccine over the weekend.
News Clip0:23
Curated Video

FDA Endorses Johnson & Johnson Single-Dose COVID-19 Vaccine

Higher Ed
The agency says the J&J COVID-19 vaccine is 66% effective at preventing moderate to sever cases of the disease.
News Clip2:33
Curated Video

CDC Panel Backs Expanded COVID Booster Rollout, OKs Mixing Shots

Higher Ed
CDC Director Dr. Rochelle Walensky had the final word on who gets the extra doses.
News Clip0:50
Curated Video

Hospitals Prepare For Spikes As School Year Starts

Higher Ed
The former head of the FDA says schools need to learn how to control outbreaks early on.
News Clip7:38
Bloomberg

Pfizer CEO Says Allocation of Covid Pill Will Be Fair

Higher Ed
Pfizer CEO Albert Bourla discusses the manufacturing and distribution plans for its Covid-19 pill, which the drugmaker says reduced hospitalizations and deaths in high-risk patients by 89%. He speaks on "Bloomberg Markets: The Close."
News Clip1:29
Curated Video

FDA Panel Endorses Moderna COVID Vaccine Booster Shot

Higher Ed
Health advisers voted unanimously to recommend a half-dose of the vaccine for seniors, the immunocompromised and those at increased risk for COVID-19.
News Clip4:50
Curated Video

CDC Panel Backs Expanded COVID Booster Rollout

Higher Ed
CDC Director Dr. Rochelle Walensky is expected to rule soon.
News Clip0:47
Curated Video

FDA Expected To Authorize Mix-And-Match COVID Booster Shots

Higher Ed
The agency is reportedly closing in on letting Americans mix COVID-19 vaccine booster shots and is not planning to recommend one shot over another.